Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR005393)
Formula
CYP2B6 ...
SVG example
Oxidationn
Reactant PF-04965842 Product Abrocitinib M1 metabolite
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 2B6 (CYP2B6) DME Info
Cytochrome P450 3A4 (CYP3A4) DME Info
Cytochrome P450 2C9 (CYP2C9) DME Info
Mephenytoin 4-hydroxylase (CYP2C19) DME Info
Metabolic Type Oxidation - Oxidationn
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005397 PF-04965842 Abrocitinib M2 metabolite Unclear PF-04965842 [1]
MR005400 PF-04965842 Abrocitinib M3 metabolite Unclear PF-04965842 [1]
MR005388 PF-04965842 Abrocitinib M4 metabolite Oxidation - Oxidationn PF-04965842 [2]
MR005403 PF-04965842 Abrocitinib M5 metabolite Unclear PF-04965842 [1]
MR012168 PF-04965842 PF-04965842 Metabolites M1 Unclear - Unclear PF-04965842 [1]
MR012178 PF-04965842 PF-04965842 Metabolites M2 Unclear - Unclear PF-04965842 [3]
MR012181 PF-04965842 PF-04965842 Metabolites M3 Unclear - Unclear PF-04965842 [3]
MR012173 PF-04965842 PF-04965842 Metabolites M4 Unclear - Unclear PF-04965842 [3]
MR012184 PF-04965842 PF-04965842 Metabolites M5 Unclear - Unclear PF-04965842 [3]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005394 Abrocitinib M1 metabolite Abrocitinib M7 metabolite Unclear PF-04965842 [1]
MR005396 Abrocitinib M1 metabolite Abrocitinib M8 metabolite Unclear PF-04965842 [1]
References
1 The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in Humans
2 Validation of enantioseparation and quantitation of an active metabolite of abrocitinib in human plasma
3 Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.